Antiseizure medication ≤48 hours portends better prognosis in new‐onset epilepsy
Publié dansEuropean journal of neurology, vol. 31, no. 2, e16107
Date de publication2023-10-27
Date de mise en ligne2023-10-27
Résumé
Mots-clés
- EEG
- MRI
- Anti-epileptic drugs
- Antiseizure medication
- First seizure
- Long-term EEG
- New-onset epilepsy
- Psychogenic
- Sleep EEG
Structure d'affiliation
- Faculté de médecine / Section de médecine clinique / Département des neurosciences cliniques
- Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences
- Faculté de médecine / Section de médecine clinique / Département de radiologie et informatique médicale
Financement
- Swiss National Science Foundation - Transcranial electrical current stimulation as a treatment in epilepsy [163398]
- Swiss National Science Foundation - Local and global brain connectivity alterations in focal epilepsy: Effects of disease, surgery and neuromodulation [169198]
- Swiss National Science Foundation - Predict and Monitor Epilepsy After a First Seizure: The Swiss-First Study [180365]
- Swiss National Science Foundation - Exploring brain communication pathways by combining diffusion based quantitative structural connectivity and EEG source imaging : application to physiological and epileptic networks [170873]
Citation (format ISO)
MENETRE, Eric et al. Antiseizure medication ≤48 hours portends better prognosis in new‐onset epilepsy. In: European journal of neurology, 2023, vol. 31, n° 2, p. e16107. doi: 10.1111/ene.16107
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:175449
- DOI : 10.1111/ene.16107
- PMID : 37889889
URL commercialhttps://onlinelibrary.wiley.com/doi/10.1111/ene.16107
ISSN du journal1351-5101